KELLY GOODMAN: Open Payments
NPI 1639396914 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 35 payments from 14 companies in 2025. Trend: 2023 $473 · 2024 $410 · 2025 $1,059
Food & beverage: $1,059
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $242 |
| Axsome Therapeutics, Inc. | 3 | $150 |
| Phathom Pharmaceuticals, Inc. | 2 | $140 |
| REVANCE THERAPEUTICS, INC. | 3 | $123 |
| PFIZER INC. | 3 | $74 |
| Galderma Laboratories, L.P. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Novo Nordisk Inc | 2 | $54 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $27 |
Products named: VOQUEZNA, Auvelity, DAXXIFY, BREZTRI, ELIQUIS, BOTOX, INSPIRE, Wegovy.
Industry payments across MD — which companies pay providers there.
